CCL17

CCL17
Available structures PDB Human UniProt search: PDBe RCSB List of PDB id codes 1NR2, 1NR4
Identifiers
Aliases	CCL17, A-152E5.3, ABCD-2, SCYA17, TARC, C-C motif chemokine ligand 17
External IDs	OMIM: 601520 MGI: 1329039 HomoloGene: 2246 GeneCards: CCL17
Gene location (Human) Chr. Chromosome 16 (human)[1] Band 16q21 Start 57,404,767 bp[1] End 57,416,063 bp[1]
Gene location (Mouse) Chr. Chromosome 8 (mouse)[2] Band 8 C5|8 46.85 cM Start 95,537,081 bp[2] End 95,538,664 bp[2]
RNA expression pattern Bgee Top expressed in lymph node appendix muscle tissue upper lobe of left lung thymus urinary bladder More reference expression data BioGPS More reference expression data
Gene ontology Molecular function cytokine activity CCR chemokine receptor binding signaling receptor binding chemokine activity CCR4 chemokine receptor binding GO:0001948 protein binding Cellular component extracellular region extracellular space Biological process G protein-coupled receptor signaling pathway negative regulation of myoblast differentiation monocyte chemotaxis chemokine-mediated signaling pathway cellular response to tumor necrosis factor cell-cell signaling neutrophil chemotaxis multicellular organism development chemotaxis GO:0032320, GO:0032321, GO:0032855, GO:0043089, GO:0032854 positive regulation of GTPase activity cellular response to interleukin-1 immune response positive regulation of ERK1 and ERK2 cascade cellular response to interferon-gamma lymphocyte chemotaxis inflammatory response antimicrobial humoral immune response mediated by antimicrobial peptide regulation of signaling receptor activity Sources:Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	6361	20295
Ensembl	ENSG00000102970	ENSMUSG00000031780
UniProt	Q92583	n/a
RefSeq (mRNA)	NM_002987	NM_011332
RefSeq (protein)	NP_002978	n/a
Location (UCSC)	Chr 16: 57.4 – 57.42 Mb	Chr 8: 95.54 – 95.54 Mb
PubMed search	[3]	[4]
Wikidata
View/Edit Human View/Edit Mouse

CCL17 is a powerful chemokine produced in the thymus and by antigen-presenting cells like dendritic cells, macrophages, and monocytes.^[5] CCL17 plays a complex role in cancer. It attracts T-regulatory cells allowing for some cancers to evade an immune response.^[6] However, in other cancers, such as melanoma, an increase in CCL17 is linked to an improved outcome.^[6] CCL17 has also been linked to allergic diseases.^[7]

Classification[]

CCL17 (CC chemokine ligand 17) was initially named TARC (thymus- and activation-regulated chemokine) when first isolated in 1996.^[7] It was later renamed CCL17 as the naming conventions for all cytokines were updated to standardize names.^[7]

Function[]

Cytokines, like CCL17, help cells communicate with one another, and stimulate cell movement. Chemokines are a type of cytokine that attract white blood cells to sites of inflammation or disease. CCL17 as well as its partner chemokine CCL22 induce chemotaxis in T-helper cells.^[5][8][9] They do this by binding to CCR4, a chemokine receptor.^[5][8][9] CCL17 is one of the few chemokines that are not stored in the body, except in the thymus; these chemokines are made when needed by dendritic cells, macrophages, and monocytes.^[5] CCL17 is expressed constitutively in the thymus, but only transiently in phytohemagglutinin-stimulated peripheral blood mononuclear cells.^[8] CCL17 can also be detected in other tissues such as the colon, small intestine, and lung.^[7] Granulocyte-macrophage colony-stimulating factor (GM-CSF) upregulates CCL17 production in monocytes and macrophages.^[10] Dendritic cells will produce large quantities of CCL17 when stimulated with IL-4 or TSLP.^[11][10]

CCL17 was the first CC chemokine identified that interacted with T cells with high affinity.^[7] CCL17 was also found to interact with monocytes, but with less affinity. It does not interact with granulocytes.^[7] It acts as a powerful chemoattractant to T-helper cells and T-regulatory cells because both can express CCR4.^[7][6]

Cancer[]

This chemokine is very important in the human body’s response to cancers. While it sometimes allows cancer to invade more rapidly, it more often helps the human body fight cancer.^[6] Some cancers that form tumors, such as breast cancer, produce CCL17 which draws T regulatory cells into the area, enhancing the cancer’s ability to invade.^[6] On the other hand, CCL17 will also activate tumor-infiltrating lymphocytes tumors.^[6] For many cancers, the more CCL17 in the area, the better the prognosis is for cancer survival or recovery.^[6]

Inflammation[]

Like many cytokines, CCL17 is inflammatory, so while it plays a largely helpful role in attacking cancers, it can induce inflammatory diseases, including allergic skin diseases. Because of its inflammatory effects, much of the medical research is on methods to mitigate CCL17. Neutralizing CCL17 with monoclonal antibodies has been shown to relieve inflammatory arthritis and osteoarthritis.^[10] Topical steroids have been found to be an effective tool in normalizing levels of CCL17.^[12]

Allergies[]

CCL17 sometimes appears to worsen allergic diseases. CCL17 is known to help lymphocytes target areas on the skin, and could play a role in treatment of dermatitis and of other allergic reactions such as asthma.^[6] However, CCL17 is thought to trigger several Th2-mediated diseases.^[7] Atopic dermatitis(eczema) has been linked to CCL17, especially in infants whose mother does not have the disease.^[12] Studies have shown that children with allergies and atopic dermatitis have higher quantiles of CCL17 compared to children without allergies.^[12]

Chromosomal location[]

In humans the gene for CCL17 is located on chromosome 16 along with other chemokines including CCL22 and CX3CL1.^[13][14]

References[]

Further reading[]

External links[]

• Human CCL17 genome location and CCL17 gene details page in the UCSC Genome Browser.

This article on a gene on human chromosome 16 is a stub. You can help Wikipedia by .

• v
• t